Jefferies Group LLC Athersys, Inc Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$1.39 - $1.71 $45,999 - $56,589
-33,093 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$1.41 - $2.16 $46,661 - $71,480
33,093 New
33,093 $48,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $28,086 - $32,918
-15,100 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$1.76 - $2.79 $26,576 - $42,129
15,100 New
15,100 $30,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email